Zobrazeno 1 - 7
of 7
pro vyhledávání: '"K. M. Latocha"'
Autor:
K. M. Latocha, K. B. Løppenthin, M. Østergaard, P. J. Jennum, R. Christensen, M. Hetland, H. Røgind, T. Lundbak, J. Midtgaard, B. A. Esbensen
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-17 (2020)
Abstract Background More than half of patients with rheumatoid arthritis complain of insomnia, which is predominantly treated with hypnotic drugs. However, cognitive behavioural therapy for insomnia is recommended as the first-line treatment in inter
Externí odkaz:
https://doaj.org/article/b7810e2b83c547be99d5676f6b066ef1
Autor:
K. M. Latocha, K. Løppenthin, M. Østergaard, P. Jennum, M. L. Hetland, H. Røgind, T. Lundbak, J. Midtgaard, R. Christensen, B. A. Esbensen
Publikováno v:
Annals of the Rheumatic Diseases. 81:196-197
BackgroundInsomnia is highly prevalent in patients with rheumatoid arthritis (RA) and may exacerbate symptoms and burdens, such as fatigue, depressive symptoms, and pain1. Cognitive behavioural therapy for insomnia (CBT-I) has been shown to produce p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9eed7dedfd556c267708ad8d2b9f623
https://doi.org/10.1136/annrheumdis-2022-eular.5164
https://doi.org/10.1136/annrheumdis-2022-eular.5164
Publikováno v:
Annals of the Rheumatic Diseases. 81:76-77
BackgroundDespite disease-modifying anti-rheumatic drugs, residual arthritis-related symptoms and burdens are still common in patients with rheumatoid arthritis (RA)1. In addition, insomnia – characterised by reduced sleep quantity and quality –
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f19aa7fb50092639b1586a6b460315c4
https://doi.org/10.1136/annrheumdis-2022-eular.4527
https://doi.org/10.1136/annrheumdis-2022-eular.4527
Autor:
J. Primdahl, K. M. Latocha, A. Bremander, O. Hendricks, M. Østergaard, L. Andersen, K. V. Jensen, B. A. Esbensen
Publikováno v:
Annals of the Rheumatic Diseases. 81:131.2-131
BackgroundUp to 30% of patients with inflammatory arthritis (IA) do not respond sufficiently or tolerate the pharmacological treatment. Consequently, they may experience a substantial impact of their arthritis in everyday life. Even patients in remis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00e586e27f8b30767e1184ff21f3ce93
https://doi.org/10.1136/annrheumdis-2022-eular.984
https://doi.org/10.1136/annrheumdis-2022-eular.984
Autor:
Mikkel Østergaard, Bente Appel Esbensen, Julie Midtgaard, Poul Jennum, K. M. Latocha, Robin Christensen, Katrine Løppenthin, Henrik Røgind, Tine Lundbak, Merete Lund Hetland
Publikováno v:
Latocha, K M, Løppenthin, K B, Østergaard, M, Jennum, P J, Christensen, R, Hetland, M, Røgind, H, Lundbak, T, Midtgaard, J & Esbensen, B A 2020, ' Cognitive behavioural therapy for insomnia in patients with rheumatoid arthritis : protocol for the randomised, single-blinded, parallel-group Sleep-RA trial ', Trials, vol. 21, 440 . https://doi.org/10.1186/s13063-020-04282-6
Trials
Trials, Vol 21, Iss 1, Pp 1-17 (2020)
Latocha, K M, Loppenthin, K B, Østergaard, M, Jennum, P J, Christensen, R, Hetland, M, Røgind, H, Lundbak, T, Midtgaard, J & Esbensen, B A 2020, ' Cognitive behavioural therapy for insomnia in patients with rheumatoid arthritis : protocol for the randomised, single-blinded, parallel-group Sleep-RA trial ', Trials, vol. 21, 440 . https://doi.org/10.1186/s13063-020-04282-6
Trials
Trials, Vol 21, Iss 1, Pp 1-17 (2020)
Latocha, K M, Loppenthin, K B, Østergaard, M, Jennum, P J, Christensen, R, Hetland, M, Røgind, H, Lundbak, T, Midtgaard, J & Esbensen, B A 2020, ' Cognitive behavioural therapy for insomnia in patients with rheumatoid arthritis : protocol for the randomised, single-blinded, parallel-group Sleep-RA trial ', Trials, vol. 21, 440 . https://doi.org/10.1186/s13063-020-04282-6
Background More than half of patients with rheumatoid arthritis complain of insomnia, which is predominantly treated with hypnotic drugs. However, cognitive behavioural therapy for insomnia is recommended as the first-line treatment in international
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aff9ceef63b2ba16c11b1f8255df29a
https://findresearcher.sdu.dk:8443/ws/files/170482599/s13063_020_04282_6.pdf
https://findresearcher.sdu.dk:8443/ws/files/170482599/s13063_020_04282_6.pdf
Autor:
Hanne Slott Jensen, Katrine Løppenthin, Bente Appel Esbensen, K. M. Latocha, T. Albrechtsen, Mette Østergaard, S. Al-Bazy, René dePont Christensen, Poul Jennum
Publikováno v:
Annals of the Rheumatic Diseases. 80:95.2-96
Background:Patients with inflammatory arthritis (IA) often present limitations in daily life due to unpredictability, severity and chronicity of the disease, reduced functional ability and health-related quality of life. Moreover, sleep disturbances
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31d13ed7107180595a59aa1e75118b62
https://doi.org/10.1136/annrheumdis-2021-eular.836
https://doi.org/10.1136/annrheumdis-2021-eular.836
Publikováno v:
Annals of the Rheumatic Diseases. 80:1466.1-1466
Background:Many patients with rheumatoid arthritis (RA) live with the consequences of arthritis in everyday life. Sleep disturbances, including insomnia, are highly prevalent and a complex issue that increases existing RA-related symptoms, such as pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d3255a137dcaf9f66d605f4e109b400
https://doi.org/10.1136/annrheumdis-2021-eular.332
https://doi.org/10.1136/annrheumdis-2021-eular.332